Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory

Jess F. Peterson, William R. Sukov, Beth A. Pitel, Stephanie A. Smoley, Kathryn E. Pearce, Reid G. Meyer, Cynthia M. Williamson, James Smadbeck, George Vasmatzis, Nicole L. Hoppman, Patricia T Greipp, Linda Baughn, Rhett P. Ketterling

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The MLLT10 (formerly AF10) gene is the fourth most common KMT2A fusion partner across all acute leukemias and requires at least 3 breaks to form an in-frame KMT2A/MLLT10 fusion due to the opposite orientation of each gene. A 10-year retrospective review was performed to identify individuals from all age groups that harbor KMT2A/MLLT10 fusion obtained by our KMT2A/MLLT10 dual-color dual-fusion fluorescence in situ hybridization (D-FISH) assay. Of the 60 unique individuals identified, 31 were male and 29 were female (M:F ratio, 1.1:1) with ages ranging from 3 days to 86 years (mean 21.5 years, median 5.5 years). The diagnoses included acute myeloid leukemia (AML) (49 patients, 82%), B- or T-lymphoblastic leukemia/lymphoma (7 patients, 12%), myeloid sarcoma (3 patients, 5%), and a single case (2%) of undifferentiated leukemia. Twenty-seven of 49 patients (55%) with AML were in the infant or pediatric age group. Fifty-three of 60 patients (88%) had KMT2A/MLLT10 D-FISH signal patterns mostly consisting of single fusions. In addition, 10 (26%) of 38 patients with conventional chromosome studies had “normal” (5 patients) or abnormal (5 patients) chromosome studies that lacked structural or numeric abnormalities involving chromosomes 10 or 11, implying cryptic cytogenetic mechanisms for KMT2A/MLLT10 fusion. Lastly, mate-pair sequencing was performed on 4 AML cases, 2 of which had “normal” chromosome studies and cryptic KMT2A/MLLT10 fusion as detected by KMT2A/MLLT10 D-FISH studies, and verified the multiple breaks required to generate KMT2A/MLLT10 fusion.

Original languageEnglish (US)
JournalGenes Chromosomes and Cancer
DOIs
StatePublished - Jan 1 2019

Fingerprint

Genomics
Leukemia
Fluorescence In Situ Hybridization
Acute Myeloid Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Age Groups
Chromosomes
Myeloid Sarcoma
Chromosomes, Human, Pair 10
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 11
Cytogenetics
Genes
Color
Pediatrics

Keywords

  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • fluorescence in situ hybridization
  • KMT2A rearrangements
  • KMT2A/MLLT10 fusion
  • mate-pair sequencing

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Peterson, J. F., Sukov, W. R., Pitel, B. A., Smoley, S. A., Pearce, K. E., Meyer, R. G., ... Ketterling, R. P. (2019). Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory. Genes Chromosomes and Cancer. https://doi.org/10.1002/gcc.22741

Acute leukemias harboring KMT2A/MLLT10 fusion : a 10-year experience from a single genomics laboratory. / Peterson, Jess F.; Sukov, William R.; Pitel, Beth A.; Smoley, Stephanie A.; Pearce, Kathryn E.; Meyer, Reid G.; Williamson, Cynthia M.; Smadbeck, James; Vasmatzis, George; Hoppman, Nicole L.; Greipp, Patricia T; Baughn, Linda; Ketterling, Rhett P.

In: Genes Chromosomes and Cancer, 01.01.2019.

Research output: Contribution to journalArticle

Peterson, Jess F. ; Sukov, William R. ; Pitel, Beth A. ; Smoley, Stephanie A. ; Pearce, Kathryn E. ; Meyer, Reid G. ; Williamson, Cynthia M. ; Smadbeck, James ; Vasmatzis, George ; Hoppman, Nicole L. ; Greipp, Patricia T ; Baughn, Linda ; Ketterling, Rhett P. / Acute leukemias harboring KMT2A/MLLT10 fusion : a 10-year experience from a single genomics laboratory. In: Genes Chromosomes and Cancer. 2019.
@article{134bbdd9b9ff4ea4813f9336cf23f1de,
title = "Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory",
abstract = "The MLLT10 (formerly AF10) gene is the fourth most common KMT2A fusion partner across all acute leukemias and requires at least 3 breaks to form an in-frame KMT2A/MLLT10 fusion due to the opposite orientation of each gene. A 10-year retrospective review was performed to identify individuals from all age groups that harbor KMT2A/MLLT10 fusion obtained by our KMT2A/MLLT10 dual-color dual-fusion fluorescence in situ hybridization (D-FISH) assay. Of the 60 unique individuals identified, 31 were male and 29 were female (M:F ratio, 1.1:1) with ages ranging from 3 days to 86 years (mean 21.5 years, median 5.5 years). The diagnoses included acute myeloid leukemia (AML) (49 patients, 82{\%}), B- or T-lymphoblastic leukemia/lymphoma (7 patients, 12{\%}), myeloid sarcoma (3 patients, 5{\%}), and a single case (2{\%}) of undifferentiated leukemia. Twenty-seven of 49 patients (55{\%}) with AML were in the infant or pediatric age group. Fifty-three of 60 patients (88{\%}) had KMT2A/MLLT10 D-FISH signal patterns mostly consisting of single fusions. In addition, 10 (26{\%}) of 38 patients with conventional chromosome studies had “normal” (5 patients) or abnormal (5 patients) chromosome studies that lacked structural or numeric abnormalities involving chromosomes 10 or 11, implying cryptic cytogenetic mechanisms for KMT2A/MLLT10 fusion. Lastly, mate-pair sequencing was performed on 4 AML cases, 2 of which had “normal” chromosome studies and cryptic KMT2A/MLLT10 fusion as detected by KMT2A/MLLT10 D-FISH studies, and verified the multiple breaks required to generate KMT2A/MLLT10 fusion.",
keywords = "acute lymphoblastic leukemia, acute myeloid leukemia, fluorescence in situ hybridization, KMT2A rearrangements, KMT2A/MLLT10 fusion, mate-pair sequencing",
author = "Peterson, {Jess F.} and Sukov, {William R.} and Pitel, {Beth A.} and Smoley, {Stephanie A.} and Pearce, {Kathryn E.} and Meyer, {Reid G.} and Williamson, {Cynthia M.} and James Smadbeck and George Vasmatzis and Hoppman, {Nicole L.} and Greipp, {Patricia T} and Linda Baughn and Ketterling, {Rhett P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/gcc.22741",
language = "English (US)",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Acute leukemias harboring KMT2A/MLLT10 fusion

T2 - a 10-year experience from a single genomics laboratory

AU - Peterson, Jess F.

AU - Sukov, William R.

AU - Pitel, Beth A.

AU - Smoley, Stephanie A.

AU - Pearce, Kathryn E.

AU - Meyer, Reid G.

AU - Williamson, Cynthia M.

AU - Smadbeck, James

AU - Vasmatzis, George

AU - Hoppman, Nicole L.

AU - Greipp, Patricia T

AU - Baughn, Linda

AU - Ketterling, Rhett P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The MLLT10 (formerly AF10) gene is the fourth most common KMT2A fusion partner across all acute leukemias and requires at least 3 breaks to form an in-frame KMT2A/MLLT10 fusion due to the opposite orientation of each gene. A 10-year retrospective review was performed to identify individuals from all age groups that harbor KMT2A/MLLT10 fusion obtained by our KMT2A/MLLT10 dual-color dual-fusion fluorescence in situ hybridization (D-FISH) assay. Of the 60 unique individuals identified, 31 were male and 29 were female (M:F ratio, 1.1:1) with ages ranging from 3 days to 86 years (mean 21.5 years, median 5.5 years). The diagnoses included acute myeloid leukemia (AML) (49 patients, 82%), B- or T-lymphoblastic leukemia/lymphoma (7 patients, 12%), myeloid sarcoma (3 patients, 5%), and a single case (2%) of undifferentiated leukemia. Twenty-seven of 49 patients (55%) with AML were in the infant or pediatric age group. Fifty-three of 60 patients (88%) had KMT2A/MLLT10 D-FISH signal patterns mostly consisting of single fusions. In addition, 10 (26%) of 38 patients with conventional chromosome studies had “normal” (5 patients) or abnormal (5 patients) chromosome studies that lacked structural or numeric abnormalities involving chromosomes 10 or 11, implying cryptic cytogenetic mechanisms for KMT2A/MLLT10 fusion. Lastly, mate-pair sequencing was performed on 4 AML cases, 2 of which had “normal” chromosome studies and cryptic KMT2A/MLLT10 fusion as detected by KMT2A/MLLT10 D-FISH studies, and verified the multiple breaks required to generate KMT2A/MLLT10 fusion.

AB - The MLLT10 (formerly AF10) gene is the fourth most common KMT2A fusion partner across all acute leukemias and requires at least 3 breaks to form an in-frame KMT2A/MLLT10 fusion due to the opposite orientation of each gene. A 10-year retrospective review was performed to identify individuals from all age groups that harbor KMT2A/MLLT10 fusion obtained by our KMT2A/MLLT10 dual-color dual-fusion fluorescence in situ hybridization (D-FISH) assay. Of the 60 unique individuals identified, 31 were male and 29 were female (M:F ratio, 1.1:1) with ages ranging from 3 days to 86 years (mean 21.5 years, median 5.5 years). The diagnoses included acute myeloid leukemia (AML) (49 patients, 82%), B- or T-lymphoblastic leukemia/lymphoma (7 patients, 12%), myeloid sarcoma (3 patients, 5%), and a single case (2%) of undifferentiated leukemia. Twenty-seven of 49 patients (55%) with AML were in the infant or pediatric age group. Fifty-three of 60 patients (88%) had KMT2A/MLLT10 D-FISH signal patterns mostly consisting of single fusions. In addition, 10 (26%) of 38 patients with conventional chromosome studies had “normal” (5 patients) or abnormal (5 patients) chromosome studies that lacked structural or numeric abnormalities involving chromosomes 10 or 11, implying cryptic cytogenetic mechanisms for KMT2A/MLLT10 fusion. Lastly, mate-pair sequencing was performed on 4 AML cases, 2 of which had “normal” chromosome studies and cryptic KMT2A/MLLT10 fusion as detected by KMT2A/MLLT10 D-FISH studies, and verified the multiple breaks required to generate KMT2A/MLLT10 fusion.

KW - acute lymphoblastic leukemia

KW - acute myeloid leukemia

KW - fluorescence in situ hybridization

KW - KMT2A rearrangements

KW - KMT2A/MLLT10 fusion

KW - mate-pair sequencing

UR - http://www.scopus.com/inward/record.url?scp=85063163939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063163939&partnerID=8YFLogxK

U2 - 10.1002/gcc.22741

DO - 10.1002/gcc.22741

M3 - Article

C2 - 30707474

AN - SCOPUS:85063163939

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

ER -